MIMEDX to Participate in Upcoming Investor Conferences
MiMedx (Nasdaq: MDXG) announced that senior management will participate in two investor conferences in New York in November 2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
MiMedx (Nasdaq: MDXG) announced that senior management will participate in two investor conferences in New York in November 2025.
Key details: Craig-Hallum 16th Annual Alpha Select Conference in New York on Tuesday, November 18, 2025 with 1:1 sessions, and Canaccord MedTech, Diagnostics and Digital Health & Services Forum in New York on Thursday, November 20, 2025 with 1:1 sessions. Investors seeking meetings should contact their Craig-Hallum or Canaccord representative.
Details
News Market Reaction – MDXG
On Nov 11, the first trading day after this news, MDXG closed 2.20% below the previous close.
Data tracked by StockTitan Argus for the Nov 11 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MARIETTA, Ga., Nov. 10, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that members of its senior management will participate in the following investor conferences:
Craig-Hallum 16th Annual Alpha Select Conference | New York, NY
Tuesday, November 18, 2025
1:1 sessions
Canaccord MedTech, Diagnostics and Digital Health & Services Forum | New York, NY
Thursday, November 20, 2025
1:1 sessions
Investors interested in meeting with senior management at these events may contact their respective Craig-Hallum or Canaccord representative.
About MIMEDX
MIMEDX is a pioneer and leader focused on helping humans heal. With more than a decade of helping clinicians manage chronic and other hard-to-heal wounds, MIMEDX is dedicated to providing a leading portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. The Company’s vision is to be the leading global provider of healing solutions through relentless innovation to restore quality of life. For additional information, please visit www.mimedx.com.
Contact:
Matt Notarianni
Investor Relations
470-304-7291
mnotarianni@mimedx.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.